Welcome to episode 048 of Life Sciences 360.

In this episode, Sharmeen discuss the current one-size-fits-all approach in healthcare and the need for precision dosing. Sharmeen explains how DoseMe platform simplifies complex dosing methods at the bedside, benefiting both clinicians and patients. Sharmeen also touch on the integration with electronic health records and the use of real-world data to improve dosing.

Shownotes :

00:00 Introduction
02:58 User Demographics
04:42 Integration with EHR
10:20 Therapeutic Areas
14:00 Bayesian Method
16:20 Real-time Data
20:20 Nerd Out on the Topic
25:00 AUC-guided Dosing
29:00 Implementation Process

-----
Links:

* Sharmeen Roy LinkedIn (https://www.linkedin.com/in/sharmeenroy/)
* DoseMe LinkedIn (https://www.linkedin.com/company/doseme-pty-ltd/ )
* DoseMe website (https://doseme-rx.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

#PrecisionDosing #BayesianDosing #HealthcareInnovation #DoseMeRx #Pharmacology #ClinicalTrials #IndividualizedMedicine #BayesianMethods #HarshThakkar #SharmeenRoy

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 047 of Life Sciences 360.

In this video, We discuss the importance of using AI in decision making in the life sciences industry. Ben highlight the need for evidence-based decision making and the challenges of finding relevant information in a sea of data. Ben introduce InVision, a platform that helps biotech and pharma companies stay informed about clinical trials and changes in the industry.

Watch the video to learn how AI can assist in making informed decisions in the life sciences field.

Chapters :
00:00 - Introduction
00:24 - AI in Decision-Making
00:45 - Welcome and Guest Introduction
01:00 - InThought Research and Infernesis
02:00 - Challenges in Clinical Trials
03:40 - InVision Technology Platform
06:36 - AI Integration in InVision
08:22 - Machine Learning and Natural Language Processing
13:20 - Case Study: Clinical Trial Data Analysis
17:56 - Privacy and Regulation in Healthcare
19:34 - AI and Job Security
24:21 -Practical Applications of AI
26:16 - Spire Bioadvisors
29:40 - Trends in Biotech and Drug Development
32:58 - Future of AI in Healthcare
37:28 - Ben's Personal Insights
39:12 - Closing Thoughts

-----
Links:

* Ben Weintraub LinkedIn (https://www.linkedin.com/in/ben-weintraub-0566389/)
* inThought Research LinkedIn (https://www.linkedin.com/company/inthought-research/ )
* inThought Research website (https://inthought.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/ )
*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment below any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel @lifesciences360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.


#AIinHealthcare #ClinicalTrials #DrugDevelopment #LifeSciences360 #BiotechStartups #PersonalizedMedicine #GeneTherapy #MachineLearning #NaturalLanguageProcessing #HealthcareInnovation

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 046 of Life Sciences 360.

On this episode, Harsh discuss the intersection of luck and preparation in finding opportunities, particularly in the field of cell therapy. Harsh share insights from his conversation with Dr. Jason Bock, founder and CEO of CTMC, about the advancements and challenges in autologous cell therapies. We delve into topics such as manufacturing, strategy formation, and the impact of cell therapy on oncology.

This episode provides valuable information for anyone interested in the field and invites viewers to explore the possibilities of this groundbreaking technology.

Show notes:

00:00 Introduction
02:40 Autologous Cell Therapies
04:40 Formation of CTMC
08:40 Recognition and Impact
11:48 Challenges in Cell Therapy Manufacturing
15:00 Acquisition of a Facility
17:20 Unexpected Growth
21:49 Houston's Support for Multi-Center Trials
27:52 Conceptualizing Virtual Manufacturing
34:20 Maintaining Focus and Vision

-----
Links:
* Jason Bock LinkedIn ( https://www.linkedin.com/in/jason-b-bock/ )
* CTMC LinkedIn
(https://www.linkedin.com/company/celltherapymanufacturingcenter/)
*CTMC website (https://ctmc.com/)
*Harsh Thakkar LinkedIn ( https://www.linkedin.com/in/harshvthakkar/)

*Listen to this episode on the go!
🍎Apple podcast: https://apple.co/3RXPoS1
🟩 Spotify podcast: https://spoti.fi/3EbDZbr

-----

#Biotech #celltherapy #MDAnderson #LifeSciences #CellManufacturing #CancerResearch #AdvancedTherapies #BiotechIndustry #MedicalResearch #InnovativeTherapies #BiotechPartnerships #BiotechCareer #Biopharmaceuticals #DigitalQuality #BiotechLeadership #IndustrialManufacturing #healthcareinnovation #MedicineMakers #Biologics #ClinicalResearch #CancerTreatment

For more, check out the podcast website - www.lifesciencespod.com

Welcome to episode 045 of Life Sciences 360.

On this episode, Nagesh Nama and his team at XLM talk on why Gen.AI is essential in the software test world and share examples of its use in various industries, particularly in life sciences and manufacturing. They address the challenges faced by companies in adopting AI and provide solutions for integrating AI into existing systems.

Harsh and his guests discuss how AI can improve productivity, enhance quality assurance processes, and enable proactive decision-making. The conversation emphasizes the importance of having an AI strategy and encourages SMBs to embrace AI to gain a competitive advantage.

-----
Links:

* Nagesh Nama LinkedIn
* xLM LinkedIn
*xLM website
*Harsh Thakkar LinkedIn
*Would you rather watch this episode? Click here for the YouTube episode.


👍 Like this video if you enjoy diving deep into the latest healthcare trends.
💬 Comment any questions you have on Generative AI. Have you implemented this into your operations yet?
🔔 Subscribe to our channel Life Sciences 360 for more expert interviews about the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

-----
Show Notes:

(0:00) Human vs. AI Diagnosis

(4:40) Using AI to Automate Clinical Trial Management Systems

(8:18) Challenges of AI adoption & Data Integrity

(13:55) Affordable AI Validation Services for SMBs

(17:55) New Companies Add AI Features, Chat GPT Stays Ahead

(21:58) How To Increase Productivity & Improve Compliance

(26:44) XLM's AI Powered Platform

(30:45) AI in Pharma

(34:57) Using AI for Supply Chain Management

For more, check out the podcast website - www.lifesciencespod.com

Dr. Arnon Chait, CEO of Cleveland Diagnostics, discusses his transition from NASA to the healthcare innovation space and the development of cancer diagnostics.

Dr. Chait emphasizes the importance of using diagnostic advancements to strike a balance between over-screening and under-treating, particularly in the workup of cancer after failed screenings. He discusses the development of their innovative prostate cancer diagnostic test.

In Episode 044 of Life Sciences 360, Harsh and Arnon also emphasize the importance of asking the right questions in scientific research and the need for simple and actionable diagnostic tools in healthcare. They advise individuals to stay curious and interested in order to be productive and successful.

-----
Links:

*Arnon LinkedIn
*Cleveland Diagnostics
*Harsh Thakkar LinkedIn
*Would you rather watch on YouTube, Click HERE


👍 Like this video if you enjoy deep dives into healthcare innovations.
🔔 Subscribe to our channel Life Sciences 360 for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors and Leave us a Review.

-----
Show Notes:

(00:00) Introduction and Background

(06:26) Choosing Cleveland as a Startup Location

(13:13) Balancing Over-Screening and Under-Treating in Cancer Diagnostics

(18:57) Proteins Involved in the Disease Process

(26:41) The Importance of a Solution that Fits the Final Application

(29:05) The Power of Curiosity and Interest in a Career

(31:18) Final Thoughts and Advice

For more, check out the podcast website - www.lifesciencespod.com

With the market estimated to reach $11.5 billion by 2028. Clean Rooms on Demand is providing flexible and cost-effective solutions for biotech and pharma companies.

The benefits of using clean rooms on demand include avoiding the high capital outlay and ongoing operational expenses of building and maintaining their own facilities, as well as the flexibility to scale up or down as needed.

Join me in Episode 43 of Life Sciences 360, with Sarah Stevens, the President of Azzur Labs and Azzur Cleanrooms on Demand, part of Azzur Group

-----
Links:

*Sarah Stevens LinkedIn
*Azzur Group
*Harsh Thakkar LinkedIn
*Would you rather watch? Click here.

-----
Show Notes:

(0:00) The Growing Cleanroom Technology Market

(3:29) Benefits of Cleanrooms on Demand

(6:41) A broader view of biotech lab solutions

(9:02) Customer Case Studies and Segments

(12:22) Expansion and Future Plans of Azzur Labs

(14:29) Global Expansion and Strategic Vision

(16:47) Sarah Stevens' Personal Career Journey

(21:26) The Azzur Culture and Team Dynamics

For more, check out the podcast website - www.lifesciencespod.com

How can behavioral science optimize pharmaceutical practices?

Episode 042: Will Hind, CEO of Alpharmaxim Healthcare Communications, discusses the challenges and opportunities in integrating behavioral science with pharma strategies.

Find out how this can lead to better patient outcomes and more tailored healthcare solutions.

-----
Links:

*Will Hind LinkedIn
*Will Hind X
*Alpharmaxim
*Harsh Thakkar LinkedIn
*Would you rather watch the episode? Click here!

📝 Leave us a review!
🔔 Subscribe to our channel, Life Sciences 360, for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

-----
Show Notes:

(0:00) Introduction to Behavioral Science in Pharma

(1:33) Why is behavior important in pharma?

(3:09) Data Analysis and Behavioral Science

(6:50) Breaking Down Barriers with Behavioral Science

(9:44) The Biggest Misconception of Behavioral Sciences

(10:52) Research & Clinical Trials

(14:49) The COM-B Model and Pharma Communication

(17:52) Multi-stakeholder Influence on Drug Adoption

(22:33) Role of Behavioral Science in Omni-channel Marketing

(26:21) Future of Behavioral Science in Pharma

For more, check out the podcast website - www.lifesciencespod.com

Episode 041: J.D. Mowery, President and CEO of KBI Biopharma, discusses his career journey and the role of CDMOs in the biotech and pharma industry. He emphasizes the importance of relationships, risk-taking, and continuous learning in his career success.

J.D. highlights the unique combination of expertise required to work in both biotech and CDMO companies. He explains the challenges faced by biotech and pharma companies that have led to the rise of CDMOs.

Harsh asks J.D. to share the key factors to consider when selecting a CDMO. They introduce the concept of a next-generation CDMO, focusing on regulatory leadership, R&D and innovation, and risk sharing.

-----
Links:

*J.D. Mowery LinkedIn
*KBI Biopharma
*Harsh Thakkar LinkedIn
*Would you rather watch the episode? Click here!

📝 Leave us a review!
🔔 Subscribe to our channel, Life Sciences 360, for more expert insights into the rapidly evolving world of life sciences.
📲 Follow us on social media to keep up with the latest news and discussions in the biotech and pharmaceutical sectors.

-----
Show Notes:

(0:00) Intro to J.D. Mowery &KBI Biopharma

(3:49) J.D.'s Journey from Biotech to CDMO

(7:17) Biopharma Challenges driving the CDMO trend

(11:47) What to Look for in a CDMO

(14:18) The 3 MOST important pillars of next-gen CDMO

(22:05) Team Leadership & Culture at KBI

(25:28) What J.D. looks for in a New Team Member

(30:32) Most Rewarding Aspect of Working in Life Sciences

(32:21) Stay in Touch with J.D.

For more, check out the podcast website - www.lifesciencespod.com